The Campaign for Sustainable Rx Pricing, of which the AHA is a founding member, today released a digital and television ad urging Congress to pass the Creating and Restoring Equal Access to Equivalent Samples Act to lower drug prices. The ad is running on CNN and Fox in Washington, DC, and on Facebook and Twitter. The CREATES Act (S. 974/H.R. 2212) would allow generic drug manufacturers facing certain anticompetitive delay tactics to bring an action in federal court for injunctive relief. More than 40 organizations, including the AHA, last month urged House and Senate leaders to pass the legislation. 

Related News Articles

Headline
The Federal Trade Commission and Department of Health and Human Services Feb. 14 requested comments for 60 days on market concentration and contracting…
Headline
The Department of Health and Human Services, Department of Justice, and Federal Trade Commission Dec. 7 announced several new actions to promote…
Headline
The companies that make the first 10 Medicare Part D drugs selected to participate in the Medicare Drug Price Negotiation Program have agreed to participate in…
Headline
The Food and Drug Administration will accept comments through Nov. 17 on draft guidance for labeling proposed biosimilar and interchangeable biosimilar…
Headline
A new Centers for Medicare & Medicaid Services fact sheet reviews how the agency selected the first 10 Part D drugs to include in the Medicare Drug Price…
Headline
The Department of Health and Human Services announced the first list of Medicare Part D drugs subject to price negotiations, a tenet of the Inflation…